003090 - Daewoong Co., Ltd.

003090 Summary
Biopharma
Stock Price & Overview
₩16,860 -340 (-1.98%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩16,860  ≈ US$12  ·  Market cap ₩1.0tn (≈ $700m)

Material matter affecting investment judgment (subsidiary)

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항(자회사의 주요경영사항) (비만치료용 세마글루타이드(4주 장기지속형 주사제) 기술도입 계약 체결)